Natalie S. Grover, MD

Articles by Natalie S. Grover, MD

CD30-Specific CAR T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma

March 6th 2019

Natalie S. Grover, MD, discusses the potential role of CD30-specific chimeric antigen receptor T cells in patients with relapsed/refractory Hodgkin Lymphoma.

Latest Updated Articles

$CD30-Specific CAR T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma$
CD30-Specific CAR T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma
Published: March 6th 2019 | Updated: